EFFICACY OF COMPLEMENT INHIBITORS AND HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A META ANALYSIS AND SYSTEMATIC REVIEW

EHA Library, Rong Fu, 4161864

LOW-DOSE CHLOROQUINE EXHIBITS SUPPRESSION OF CTLS MEDIATED BY NK CYTOTOXICITY IN SEVERE APLASTIC ANEMIA

EHA Library, Tong Chen, 4161865

A REAL-WORLD, MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY FOR PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH) IN CHINA: PRELIMINARY RESULTS

EHA Library, Rong Fu, 4161867

DOSE DETERMINATION FOR A RARE INDICATION: PHASE 3 DOSE OF ZALTENIBART, AN INVESTIGATIONAL MASP-3 INHIBITOR, FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, William Pullman, 4161868

LP-005, A BIFUNCTIONAL C5 ANTIBODY FUSION PROTEIN, EFFECTIVELY CONTROLS BOTH HEMOLYSIS: INTERIM RESULTS FROM A PHASE 2 STUDY

EHA Library, Guangsheng He, 4161869

COMPREHENSIVE ANALYSIS OF THE CLINICAL FEATURE, MYELOID NEOPLASM-RELATED GENE MUTATION PROFILES AND T CELL DIVERSITY IN 168 PATIENTS WITH ACQUIRED PURE RED CELL APLASIA

EHA Library, Guangsheng He, 4161870

A STUDY ON FLUDARABINE, CYCLOPHOSPHAMIDE, AND MELPHALAN (FCM) PRECONDITIONING IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA: A PROSPECTIVE, MULTICENTER, SINGLE-ARM CLINICAL STUDY

EHA Library, Xiaoping Li, 4161871

EFFICACY OF FULMINANT APLASTIC ANEMIA TO INTENSIVE IMMUNOSUPPRESSIVE THERAPY (IST) IS INFERIOR TO THAT OF SEVERE APLASTIC ANEMIA, VERY SEVERE APLASTIC ANEMIA: A PROSPECTIVE REGISTRY STUDY REPORT

EHA Library, Guangsheng He, 4161872

A SINGLE INSTITUTION EXPERIENCE OF IPTACOPAN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Mark Orland, 4161873

NETWORK META-ANALYSIS COMPARING THE EFFICACY OF DIFFERENT COMPLEMENT PATHWAY INHIBITORS FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMATURIA

EHA Library, Eri Matsuki, 4161874

PROLONGED USE OF LOW DOSAGE ELTROMBOPAG IN CHINESE PATIENTS WITH SEVERE APLASTIC ANEMIA IN THE REAL WORLD

EHA Library, Guangsheng He, 4161875

ANALYSIS OF TELOMERE LENGTH DYNAMICS IN PATIENTS WITH APLASTIC ANEMIA DURING IMMUNISUPRESSIVE THERAPY

EHA Library, Anton luchkin, 4161876

APLASTIC ANAEMIA: 10 YEAR OUTCOMES IN A SOUTH AFRICAN TRANSPLANT CENTRE.

EHA Library, Marthinus Dicks, 4161877

ASSESSMENT OF LONG-TERM RENAL FUNCTION IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH RAVULIZUMAB IN A PHASE 3 OPEN-LABEL STUDY

EHA Library, Srikanth Nagalla, 4161878

HEMATOLOGIC FEATURES OF VEXAS SYNDROME IN MEXICAN PATIENTS: A RETROSPECTIVE STUDY

EHA Library, Lyam Carlo Chacon-Rangel, 4161879

OBTAINING INSIGHTS ON PNH MANAGEMENT WITH IPTACOPAN IN EVERYDAY CLINICAL PRACTICE: A RESEARCH COLLABORATION WITH THE IPIG PNH REGISTRY

EHA Library, Richard J Kelly, 4161880

ASSESSMENT OF CHARACTERISTICS AND TREATMENT PATTERNS OF ADULT PATIENTS WITH ACQUIRED APLASTIC ANAEMIA IN TURKIYE (PLANE-TR STUDY)

EHA Library, Eren Gunduz, 4161881

EVALUATION OF HAEMATOLOGY PHYSICIANS' AWARENESS OF AND REFERRAL TO APLASTIC ANAEMIA PATIENT ADVOCACY GROUPS

EHA Library, Fabian Beier, 4161882

ENHANCING OUTCOMES IN HEPATITIS-ASSOCIATED APLASTIC ANEMIA: THE ROLE OF THROMBOPOIETIN RECEPTOR AGONISTS AS AN ADJUNCT TO STANDARD IMMUNOSUPPRESSIVE THERAPY

EHA Library, Meili Ge, 4161883

SINGLE-CENTER RETROSPECTIVE ANALYSIS OF DIFFERENT THROMBOPOIESIS-STIMULATING THERAPY REGIMENS IN SEVERE APLASTIC ANEMIA

EHA Library, Rong Fu, 4161884

LONG-TERM SAFETY OF SB12 IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: UP TO 2-YEAR EXTENSION TREATMENT SAFETY DATA

EHA Library, Jun Ho Jang, 4161885

SYSTEMATIC MAPPING OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA RESOURCES: IDENTIFYING GAPS IN CLINICAL EDUCATION TOOLS TO IMPROVE DIAGNOSIS AND PATIENT CARE

EHA Library, Gulin Kayserili, 4161886

A SINGLE CENTER REAL-WORLD STUDY ON THE EFFICACY AND RECOVERY OF INFLAMMATORY CYTOKINE LEVELS OF C5 COMPLEMENT INHIBITOR THERAPY IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA PATIENTS

EHA Library, Rong Fu, 4161887

THE PREDICTIVE VALUE OF NUTRITIONAL STATUS AND BLOOD INDICES FOR ADVERSE REACTIONS IN IMMUNOSUPPRESSIVE THERAPY FOR APLASTIC ANEMIA PATIENTS

EHA Library, LI Xinli, 4161888

POSITIVE ANTI-NEUTROPHIL ANTIBODIES IN EARLY CHILDHOOD MAY BE DETECTED IN ENTITIES OTHER THAN PRIMARY AUTOIMMUNE NEUTROPENIA.

EHA Library, Konstantina Toutoudaki, 4161889

TREATMENT BURDEN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH INTRAVENOUS C5 INHIBITORS: AN IN-DEPTH INTERVIEW SURVEY STUDY

EHA Library, Naoshi Obara, 4161890

COMBINATION OF CYCLOSPORINE AND ELTROMBOPAG AS A FIRST LINE THERAPY IN PATIENTS WITH APLASTIC ANEMIA: A SINGLE CENTER EXPERIENCE FROM A DEVELOPING NATION.

EHA Library, Aritra Saha, 4161891

CONSENSUS ALGORITHM FOR SCREENING AND DIAGNOSIS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN GREECE: INSIGHTS FROM A MULTI-SPECIALTY EXPERT DELPHI-PANEL

EHA Library, Vasiliki Antonopoulou, 4161892

A SINGLE CENTER REAL-WORLD ANALYSIS:CLINICAL CHARACTERISTICS AND PREDICTION OF THROMBOSIS RISK IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Rong Fu, 4161893

SPLENECTOMY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND PRE-HEPATIC PORTAL HYPERTENSION

EHA Library, Vitalii Latyshev, 4161894

TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS WITH COMPLEMENT INHIBITORS - EXPERIENCE OF A SINGLE CENTER

EHA Library, Jaroslav Cermak, 4161895

REAL-WORLD EFFECTIVENESS OF RAVULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: THE US POLESTAR CHART REVIEW STUDY

EHA Library, David Dingli, 4161896

FEMALE GENDER IS PROBABLY ASSOCIATED WITH WORSE HEMATOLOGIC RESPONSE TO C5 INHIBITORS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Vitalii Latyshev, 4161897

COMPLICATIONS IN THE MEDIUM AND LONG TERM OF ACQUIRED APLASTIC ANEMIA IN ADULTS N. ZATOUT, H. HAMOUDA. HEMATOLOGY DEPARTMENT - UNIVERSITY HOSPITAL OF SÉTIF, ALGERIA.

EHA Library, zatout nisrine, 4161899

CLINICAL FEATURES AND OUTCOMES OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS TREATED WITH ECULIZUMAB IN TAIWAN: A MULTICENTER RETROSPECTIVE ANALYSIS

EHA Library, Hsing-Yu Lin, 4161901

MANAGEMENT OF A COMPLEX CASE OF ACTIVATED PI3KΔ SYNDROME-1 (APDS-1) IMPROVED BY LENIOLISIB: A CASE REPORT

EHA Library, Panagiotis Dolgyras, 4161902

PURE RED CELL APLASIA FOLLOWING COVID-19: CLINICAL INSIGHTS AND TREATMENT OUTCOMES

EHA Library, Shehab Fareed Abdelgabber, 4161903

EFFICACY OF RITUXIMAB PLUS GLUCOCORTICOIDS FOR PLATELET TRANSFUSION REFRACTORINESS IN SERIOUS APLASTIC ANEMIA

EHA Library, Jinbo Huang, 4161904

EFFICACY OF SCREENING FOR PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA - REAL-WORLD EXPERIENCE

EHA Library, Ana Boban, 4161905

CLINICAL STUDY ON AUTOLOGOUS STEM CELL TRANSPLANTATION FOR THE TREATMENT OF RETINOBLASTOMA

EHA Library, Yuan Sun, 4161906

INVESTIGATING THE MECHANISMS OF BUSHEN SHENGXUE DECOCTION COMBINED WITH CYCLOSPORINE AND STANOZOLOL TABLETS IN TREATING APLASTIC ANEMIA VIA INTEGRATED METABOLOMICS AND 16S RRNA SEQUENCING: A SINGLE-ARM STUDY

EHA Library, Siyuan Cui, 4161907

OUTCOME OF IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED APLASTIC ANEMIA: EXPERIENCE FROM A LOW MIDDLE INCOME COUNTRY

EHA Library, Vineeta Gupta, 4161908

TWO CASES OF BONE MARROW FAILURE AFTER RADIOTHERAPY AND CHEMOTHERAPY IN FANCONI ANEMIA TYPE D1 WITH CONCOMITANT MEDULLOBLASTOMA AND LITERATURE REVIEW

EHA Library, Yuan Sun, 4161909

FROM MISDIAGNOSIS TO REVELATION: A COMPLEX CASE OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PRESENTING AS REFRACTORY THROMBOCYTOPENIA

EHA Library, Pyrus Bhellum, 4161910

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND MYELODYSPLASIA: A RETROSPECTIVE ANALYSIS FROM A HEMATOLOGY CENTER.

EHA Library, H Tilman Steinmetz, 4161911

OUTCOME OF PATIENTS OVER 50 YEARS OLD WITH ACQUIRED SEVERE APLASTIC ANEMIA INELIGIBLE FOR TRANSPLANT: A SINGLE-CENTER STUDY IN MEXICO CITY.

EHA Library, María Elena Monserrat Luna Pérez, 4161912

A NON-INTERVENTIONAL CLINICAL AUDIT STUDY INVESTIGATING DIAGNOSTIC EFFICIENCY FOR GAUCHER DISEASE

EHA Library, Colm Bradley, 4161913

SEVERE CONGENITAL NEUTROPENIA FROM A NOVEL MUTATION SER126LEU OF ELANE GENE: A CASE REPORT

EHA Library, Jing He, 4161914

THE ROLE OF SERUM IGM IN BCR SIGNALING AND DRUG RESISTANCE IN IGM-SECRETING B LYMPHOMAS

EHA Library, Palash Chandra Maity, 4161915

PHENOTYPING THE COAGULATION OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH THROMBOMODULIN-MODIFIED THROMBIN GENERATION.

EHA Library, Emilie Chalayer, 4161916

CORRELATION OF EXPRESSION OF MAJOR ENZYMES IN NAD+ SYNTHESIS WITH OVERALL SURVIVAL IN MULTIPLE MYELOMA

EHA Library, Lara Crone, 4161917

IDENTIFICATION OF FEGFR2 AS A NEW THERAPEUTIC TARGET FOR K-RAS-MUTATED MYELOMA

EHA Library, Ichiro Hanamura, 4161918

LOW-DOSE INVOLVED-SITE RADIOTHERAPY (LD-ISRT) COMBINED WITH HDAC INHIBITORS AS A BRIDGE TO CAR T-CELL THERAPY IN HEAVILY PRETREATED RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) AND NON-HODGKIN LYMPHOMA (NHL) WITH EXTRAMEDULLARY OR EXTRANODAL INVOLVEMENT: A SINGLE-CENTER, INVESTIGATOR-INITIATED STUDY

EHA Library, yajing zhang, 4161919

AUTOMATED DETECTION AND COMPREHENSIVE SPATIAL PROFILING IN PLASMA CELL DYSCRASIAS

EHA Library, Anna Sozanska, 4161920

BREAKING THROUGH THE DARKNESS OF RESISTANCE IN MULTIPLE MYELOMA: HNRNPK AS A NEW HORIZONT IN TREATMENT

EHA Library, Álvaro Otero-Sobrino, 4161921

PLASMA SPHINGOLIPIDOMICS FOR EXPLORING PROGNOSTIC BIOMARKERS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Zekun Li, 4161922

EPIGENETIC MODIFICATIONS OF THE PHOX2A AND CDH2 GENES - NEW INSIGHTS INTO THE PATHOGENESIS OF MULTIPLE MYELOMA.

EHA Library, Karolina Łuczkowska, 4161923

THE BCMA NK CELL ENGAGER SAR'514 INDUCES MACROPHAGE-MEDIATED PHAGOCYTOSIS WHICH IS IMPROVED BY COMBINATION WITH EVORPACEPT, A CD47 BLOCKER, IN MULTIPLE MYELOMA

EHA Library, Alexandre Tang, 4161924

MRD-TESTING IN MULTIPLE MYELOMA IN BELGIUM: DATA FROM THE MMOVE PROJECT

EHA Library, Marleen Bakkus, 4161925

SPATIAL IDENTIFICATION OF NEURONAL FIBERS AND MICROENVIRONMENTAL CELLS IN MULTIPLE MYELOMA BONE MARROW BIOPSIES AND THEIR POTENTIAL INFLUENCE ON PLASMA CELL DISTRIBUTION

EHA Library, Ana Filipa Barahona, 4161926

RNA SEQUENCING-BASED DETECTION OF PLASMA CELL CLONALITY AND CLONOTYPES IN PATIENTS WITH MULTIPLE MYELOMA.

EHA Library, Anna Sergeeva, 4161927

COMBINING PIM-2 AND PARP1 INHIBITORS INDUCES MICA EXPRESSION ON MULTIPLE MYELOMA CELLS TO ACTIVATE NK CELLS THROUGH NKG2D BINDING

EHA Library, Rong Fu, 4161928

FASTER MYELOMA MONITORING USING MACHINE LEARNING FOR M-SPIKE PREDICTIO

EHA Library, Ehsan Malek, 4161929

T CELL EXHAUSTION IN MULTIPLE MYELOMA: IMMUNOLOGICAL DYSFUNCTION AND THERAPEUTIC IMPLICATIONS

EHA Library, Paula Piñero, 4161930

THE INFLUENCE OF VITAMIN 25(OH)D AND K2MK7 ON THE DEVELOPMENT OF MULTIPLE MYELOMA CELLS UNDER HYPOXIC/PHYSIOLOGICAL CONDITIONS.

EHA Library, Karolina Łuczkowska, 4161931

STING DRIVES MULTIPLE MYELOMA PROGRESSION VIA CELL CYCLE DYSREGULATION AND APOPTOSIS SUPPRESSION

EHA Library, chunlan huang, 4161932

EVOLUTION OF CYTOGENETIC PROFILES IN MULTIPLE MYELOMA: A RETROSPECTIVE ANALYSIS OF FISH CHANGES

EHA Library, Jorge Hurtado Martinez, 4161933

BIOLOGICAL FUNCTION AND PROGNOSTIC VALUE OF RAB26 IN PAN-CANCER: FOCUS ON ITS ROLE IN PREDICTING DISEASE PROGRESSION IN MULTIPLE MYELOMA

EHA Library, Bingjie Fan, 4161934

LINKING SURFACE PROTEIN EXPRESSION WITH CYTOGENETIC AND MOLECULAR GENETIC ALTERATIONS IN NEWLY DIAGNOSED MYELOMA PATIENTS

EHA Library, Veronika Ecker, 4161935

USE OF BIOSIMULATION TO PREDICT INDIVIDUAL PATIENT RESPONSE TO ANTI-CD38 THERAPY WHEN COMBINED WITH EITHER LENALIDOMIDE OR BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, James Wingrove, 4161936

GENETIC POLYMORPHISM IN NRAS, KRAS, BRAF GENES IN MULTIPLE MYELOMA

EHA Library, Zhanna Kozich, 4161937

CYTOGENETIC RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Tatiana Obukhova, 4161938

EARLY PHENOTYPIC T CELLS CHANGES PREDICT THE RESPONSE TO CD3XBCMA BISPECIFIC ANTIBODIES IN MULTIPLE MYELOMA

EHA Library, Yannick Simoni, 4161939

TRANSCRIPTOMIC ANALYSIS IDENTIFIES MOLECULAR DIFFERENCES BETWEEN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA THAT LEAD TO RESPONSE OR RESISTANCE TO INDUCTION THERAPY WITH PAD/VCD REGIMENS.

EHA Library, Anna Sergeeva, 4161940

THE MECHANISM OF STAT3 INHIBITORS INDUCING DNA DAMAGE IN MULTIPLE MYELOMA CELLS AND ENHANCING THE ANTI-TUMOR EFFECTS OF NK CELLS

EHA Library, Rong Fu, 4161941

IDENTIFICATION OF CERNA REGULATORY NETWORKS DRIVEN BY THE LNCRNA NEAT1 IN MULTIPLE MYELOMA

EHA Library, Domenica Ronchetti, 4161942

HAPLOTYPES IN THE IL-4 GENE IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Elena Kuzmich, 4161943

CAUSAL RELATIONSHIPS BETWEEN CEREBRAL CORTICAL ARCHITECTURE AND BLOOD CANCERS: THE DISEASE SPECTRUM IS DIFFERENT BECAUSE THE BRAINS LOOK DIFFERENT

EHA Library, Yue Wang, 4161944

CIRCULATING PLASMA LONG NON-CODING RNA GAS5 AS NON-INVASIVE BIOMARKER IN MULTIPLE MYELOMA PATIENTS

EHA Library, Anica Pravdić Divac, 4161945

HIGH EXPRESSION OF CIRCULATING MICRORNA-98 AND MICRORNA-4458 CORRELATES WITH POOR PROGNOSIS IN MULTIPLE MYELOMA PATIENTS.

EHA Library, Aneta Szudy-Szczyrek, 4161946

THE DIAGNOSTIC POTENTIAL OF CIRCULATING MICRORNA AND PLASMA GALECTIN-3 IN DISEASE PROGRESSION AND SKELETAL COMPLICATIONS IN MULTIPLE MYELOMA (MM)

EHA Library, Mosavar Farahani, 4161948

A WITHANOLIDE ANALOGUE INDUCES CELL CYCLE ARREST IN MULTIPLE MYELOMA CELL MODELS THROUGH KEY CANCER REGULATORS: IKAROS AND AIOLOS

EHA Library, Albane Zingg, 4161949

HARNESSING CNTN5: A NOVEL BIOMARKER FOR PRECISION RISK STRATIFICATION AND IMMUNE DYSFUNCTION MONITORING IN MULTIPLE MYELOMA

EHA Library, Vanessa Desantis, 4161950

ENHANCED MONITORING AND PROGNOSTIC INSIGHTS IN MULTIPLE MYELOMA USING HEVYLITE® ASSAY: A REAL-LIFE COMPREHENSIVE STUDY

EHA Library, Antonio Garcia-Guiñon, 4161951

EFFICACY AND SAFETY OF SELINEXOR-MELPHALAN COMBINED CONDITIONING REGIMEN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

EHA Library, Shuai Su, 4161952

REFRACTORY CYTOMEGALOVIRUS INFECTION AND PROLONGED IMMUNE DEFICIENCY FOLLOWING BCMA-DIRECTED CAR-T CELL THERAPY: IMPLICATIONS FOR INFECTIOUS DISEASE SURVEILLANCE AND MANAGEMENT

EHA Library, Yoko Tamamushi, 4161953

IMMUNOPHENOTYPIC DIFFERENCES AND IMMUNOMODULATORY MOLECULE EXPRESSION ON PLASMA CELLS IN MULTIPLE MYELOMA PATIENTS WITH VARYING DEGREES OF BONE MARROW INVOLVEMENT

EHA Library, Alicja Dudzik, 4161954

AMPLIFYING T CELL SPECIFIC ANTI-TUMOR IMMUNE RESPONSES VIA INDUCING IMMUNOGENIC CELL DEATH IN MULTIPLE MYELOMA IMMUNOTHERAPY

EHA Library, Zhaoyun Liu, 4161955

MECHANISMS OF THE KIDNEY-REINFORCING AND BLOOD CIRCULATION-ACTIVATING AND DREDGING COLLATERALS DECOCTION MEDICATED SERUM IN REGULATING MITOCHONDRIAL FISSION TO INDUCE AUTOPHAGY AND APOPTOSIS IN MULTIPLE MYELOMA U266 CELLS

EHA Library, Siyuan Cui, 4161956

CD56 EXPRESSION AS A PROGNOSTIC MARKER IN MULTIPLE MYELOMA: A RETROSPECTIVE COHORT STUDY

EHA Library, Gevorg Avagyan, 4161957

DARATUMUMAB: A MONOCLONAL ANTIBODY CAPABLE OF CAUSING DIAGNOSTIC ERRORS DUE TO KAPPA LIGHT CHAIN RESTRICTION IN DIFFERENT BONE MARROW CELLS.

EHA Library, JONE ALBERDI BALLINA, 4161958

SYSTEMATIC REVIEW OF BISPECIFIC ANTIBODIES EFFICACY AND SAFETY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Judith Pérez-Granado, 4161959

CHALLENGES IN MONOCLONAL PROTEIN DETECTION AND QUANTIFICATION: A TERTIARY HOSPITAL EXPERIENCE IN SOUTH KOREA

EHA Library, Mikyoung Park, 4161960

MINIMAL RESIDUAL DISEASE ASSESSMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA: A SINGLE-CENTER STUDY

EHA Library, Soudamini Mahapatra, 4161961

GASTROINTESTINAL SYMPTOMS AS AN INITIAL MANIFESTATION OF MULTIPLE MYELOMA: A CASE REPORT.

EHA Library, Nadia Bennai, 4161962

MONOCLONAL GAMMOPATHY IN THE α-2 REGION ON PROTEIN ELECTROPHORESIS: A CASE REPORT AND LITERATURE REVIEW

EHA Library, Mikyoung Park, 4161963

CLINICOPATHOLOGIC FEATURES OF 86 PATIENTS WITH TP53 MUTATED MULTIPLE MYELOMA

EHA Library, Fatima Zahra Jelloul, 4161964

BELANTAMAB MAFODOTIN PLUS BORTEZOMIB/DEXAMETHASONE SHOWS SIMILAR PROGRESSION-FREE SURVIVAL TO CILTACABTAGENE AUTOLEUCEL IN PATIENTS WITH RELAPSED /REFRACTORY MULTIPLE MYELOMA: A NETWORK META-ANALYSIS

EHA Library, Jun Ho Yi, 4161965

COMBINATION PARTNERS IMPACT ON OUTCOME OF CD38 ANTIBODY TREATMENT IN SECOND LINE: REAL WORLD DATA OF THE MULTIPLE MYELOMA REGISTRY OF THE EAST GERMAN STUDY GROUP HEMATOLOGY/ONCOLOGY (OSHO)

EHA Library, Sebastian Böttcher, 4161966

SOLUBLE BCMA AS A PROGNOSTIC BIOMARKER IN MULTIPLE MYELOMA: INSIGHTS FROM A META-ANALYSIS

EHA Library, Jaroslaw Dybko, 4161967